ABSTRACT
The worldwide economic impact of Neospora caninum infection has caused the development of effective vaccines to become one of the main goals in the field of neosporosis research. In this study, the protection conferred by antigens from inactivated whole tachyzoites (TZ) and a tachyzoite-bradyzoite mixture (TZ-BZ) of N. caninum (Nc-Spain7 isolate) incorporated into a water-in-oil emulsion (W/O) and aluminium hydroxide-ginseng extract (Al/G) was evaluated in mouse models of congenital and cerebral N. caninum infection. Immunization with TZ-BZ induced congenital and cerebral neosporosis exacerbation that was mainly characterized by reduced neonatal median survival time and increased parasite presence in adult mouse brains. The immune response of mice immunized with TZ-BZ was characterized by an increase in IFN-γ expression prior to challenge and an increase in IL-4 expression accompanied with significantly higher levels of antibodies against 2 recombinant bradyzoite-specific proteins (rNcSAG4 and rNcBSR4) after challenge. Immunization with TZ in W/O significantly reduced neonatal mortality, vertical transmission as well as parasite presence in adult mouse brains and induced a strong humoral immune response. The current study demonstrates the critical role of stage-specific antigens and adjuvants on the development of effective inactivated vaccines for the prevention of N. caninum infection.
Subject(s)
Adjuvants, Immunologic/administration & dosage , Antibodies, Protozoan/biosynthesis , Coccidiosis/prevention & control , Immunization , Life Cycle Stages/immunology , Neospora/immunology , Protozoan Vaccines/administration & dosage , Vaccines, Inactivated/administration & dosage , Adjuvants, Immunologic/chemistry , Animals , Animals, Newborn , Antibodies, Protozoan/immunology , Cattle , Coccidiosis/immunology , Coccidiosis/parasitology , Enzyme-Linked Immunosorbent Assay , Female , Immunity, Humoral/drug effects , Immunization/mortality , Infectious Disease Transmission, Vertical/prevention & control , Interferon-gamma/analysis , Interferon-gamma/biosynthesis , Interleukin-4/analysis , Interleukin-4/biosynthesis , Mice , Mice, Inbred BALB C , Polymerase Chain Reaction , Pregnancy , Protozoan Vaccines/immunology , Protozoan Vaccines/metabolism , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Vaccines, Inactivated/immunology , Vaccines, Inactivated/metabolismABSTRACT
Neospora caninum is one of the more-efficient transplacentally-transmitted organisms. The goal of the present study was to investigate the pathologic and immunologic changes that occur at the materno-fetal interphase in pregnant BALB/c mice infected with N. caninum at mid-gestation. Parasite DNA was detected in feto-placentary units 3 days post-infection (PI). On day 7 PI, the DNA detection level and parasite burden were significantly higher in the placentas than in the fetuses, which may indicate that the parasite is mainly multiplying in the placenta during the initial infection. In the spleens of infected dams, we observed an increase in IFN-γ, IL-10, and IL-4. However, only IL-4 was upregulated in placentas from the infected dams; this may enhance susceptibility to N. caninum at the materno-fetal interphase and favor transmission to the progeny. Finally, an increase in TNF-α expression in nested-PCR-positive placentas combined with necrosis may compromise the viability of the fetuses.
Subject(s)
Coccidiosis/pathology , Neospora/physiology , Placenta/parasitology , Pregnancy Complications, Parasitic/pathology , Animals , Coccidiosis/immunology , Coccidiosis/parasitology , DNA, Protozoan/analysis , Disease Models, Animal , Female , Fetal Death/parasitology , Fetal Resorption/parasitology , Fetus/parasitology , Gene Expression , Interferon-gamma/genetics , Interferon-gamma/metabolism , Interleukin-10/genetics , Interleukin-10/metabolism , Interleukin-4/genetics , Interleukin-4/metabolism , Mice , Mice, Inbred BALB C , Neospora/growth & development , Neospora/immunology , Placenta/immunology , Placenta/pathology , Polymerase Chain Reaction , Pregnancy , Pregnancy Complications, Parasitic/immunology , Pregnancy Complications, Parasitic/parasitology , RNA, Messenger/metabolism , Spleen/immunology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolismABSTRACT
The influence of Neospora caninum infection during pregnancy on the post-natal period has been poorly investigated. In a previous study, we suggested that infection with N. caninum during pregnancy could affect the normal post-natal development of the offspring. For this reason, in the present work we evaluated the influence of N. caninum infection in pregnant BALB/c mice at days 0, 7 and 14 of gestation (groups A, B and C, respectively) on the post-natal development of the offspring from birth to day 60 post-partum (PP). Morbidity and mortality, vertical transmission, and histopathological lesions were investigated. The humoral immune response (IgG) of pups was also evaluated. Results showed that infection with N. caninum during pregnancy had fatal consequences for pups, especially during mid-gestation (day 7). Infection provoked a delay in the general development of neonates, clinical signs compatible with neosporosis and severe histopathological lesions. A high mortality rate was found in all infected groups. A 69% of mortality rate was found in group A, a 100% in group B and a 46% in group C. Necrotizing encephalitis and multifocal hepatocellular necrosis were the most severe lesions found. All neonates, except four animals from group C, had antibodies against N. caninum but the immune response was not sufficient to control parasite infection. We have demonstrated that extension of the observation period after N. caninum infection permits a more accurate study of vertical transmission, the major route of parasite transmission, and mortality rates. We propose that infection at mid-gestation (day 7) in BALB/c mice and its study during the post-natal period constitutes a valuable experimental model for testing new chemotherapeutic agents and vaccines designed to protect against congenital neosporosis, in order to select effective protocols before its use on bovine.